Therapeutic options for infections withEnterobacteriaceaeproducing carbapenem-hydrolyzing enzymes
出版年份 2011 全文链接
标题
Therapeutic options for infections withEnterobacteriaceaeproducing carbapenem-hydrolyzing enzymes
作者
关键词
-
出版物
Future Microbiology
Volume 6, Issue 6, Pages 653-666
出版商
Future Medicine Ltd
发表日期
2011-06-28
DOI
10.2217/fmb.11.49
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Serum Bactericidal Activity of Three Different Dosing Regimens of Colistin with Implications for Optimum Clinical Use
- (2014) G.L. Daikos et al. JOURNAL OF CHEMOTHERAPY
- In VitroInteractions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development
- (2011) Maria Souli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroPharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination againstKlebsiella pneumoniaeIsolates Producing a KPC Carbapenemase
- (2011) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Outbreak of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in France
- (2011) Gaelle Cuzon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assay
- (2011) Spyros Pournaras et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Adaptive resistance to cationic compounds in Pseudomonas aeruginosa
- (2011) Anna Skiada et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
- (2011) G. Meletis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Does broad-spectrum -lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?
- (2011) P. Nordmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Aerosol Delivery of Antimicrobial Agents During Mechanical Ventilation: Current Practice and Perspectives
- (2011) Argyris Michalopoulos et al. Current Drug Delivery
- Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-ProducingEnterobacteriaceae
- (2010) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii
- (2010) M. M. Sopirala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Penem-1 in Combination with -Lactams against blaKPC-Possessing Klebsiella pneumoniae Isolates
- (2010) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Extremely Drug-ResistantCitrobacter freundiiIsolate Producing NDM-1 and Other Carbapenemases Identified in a Patient Returning from India
- (2010) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Amikacin Monotherapy for Sepsis Caused by Panresistant Pseudomonas aeruginosa
- (2010) B. Layeux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymyxin-Resistant Clinical Isolates ofEscherichiacoli
- (2010) Carl Urban et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae
- (2010) B. Kitchel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Metallo- -Lactamase NDM-1-Producing Multidrug-Resistant Escherichia coli in Australia
- (2010) L. Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ceftazidime and NXL104 in Two Murine Models of Infection Due to KPC-ProducingKlebsiella pneumoniae
- (2010) Andrea Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Spread of OXA-48-Encoding Plasmid in Turkey and Beyond
- (2010) A. Carrer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Efficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase- Producing Klebsiella pneumoniae
- (2010) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Dissemination of NDM-1- and OXA-181-ProducingEnterobacteriaceaein Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007
- (2010) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Outbreak of Colistin-Resistant, Carbapenem-ResistantKlebsiella pneumoniaein Metropolitan Detroit, Michigan
- (2010) Dror Marchaim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Susceptibility to Various Antibiotics of Colistin‐Resistant Gram‐Negative Bacterial Isolates in a General Tertiary Hospital in Crete, Greece
- (2010) George Samonis et al. CLINICAL INFECTIOUS DISEASES
- Tigecycline and Bacteremia—The Dangers of Post Hoc Analysis of Pooled Data
- (2010) Giorgio Tarchini CLINICAL INFECTIOUS DISEASES
- Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator‐Associated Pneumonia: A Matched Case‐Control Study
- (2010) Diamantis P. Kofteridis et al. CLINICAL INFECTIOUS DISEASES
- Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
- (2010) Y. Carmeli et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes
- (2010) May Nguyen et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
- (2010) Antonio T. Freire et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Resistance to polymyxins: Mechanisms, frequency and treatment options
- (2010) Matthew E. Falagas et al. DRUG RESISTANCE UPDATES
- Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary
- (2010) Á. Tóth et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- New β-lactam antibiotics and β-lactamase inhibitors
- (2010) Karen Bush et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Natural History of Colonization with Gram-Negative Multidrug-Resistant Organisms among Hospitalized Patients
- (2010) Amy C. Weintrob et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- The Antibiotic Development Pipeline for Multidrug-Resistant Gram-Negative Bacilli: Current and Future Landscapes
- (2010) George H. Talbot INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin
- (2010) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2
- (2010) A. Zioga et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns
- (2010) Volker Strenger et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin
- (2010) M. Vaara et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of carbapenems against a metallo- -lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model
- (2010) M. Souli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 -lactamase
- (2010) T. Naas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo- -lactamase
- (2010) A. Poulou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
- (2010) P. Rattanaumpawan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
- (2010) Elizabeth B. Hirsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem Heteroresistance in VIM-1-Producing Klebsiella pneumoniae Isolates Belonging to the Same Clone: Consequences for Routine Susceptibility Testing
- (2010) M. Tato et al. JOURNAL OF CLINICAL MICROBIOLOGY
- In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
- (2010) A. Elemam et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Characteristics of Meropenem Heteroresistance in Klebsiella pneumoniae Carbapenemase (KPC)-Producing Clinical Isolates of K. pneumoniae
- (2010) S. Pournaras et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Risk Factors and Outcomes Associated with Acquisition of Colistin-Resistant KPC-Producing Klebsiella pneumoniae: a Matched Case-Control Study
- (2010) O. Zarkotou et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Global spread of New Delhi metallo-β-lactamase 1
- (2010) Laurent Poirel et al. LANCET INFECTIOUS DISEASES
- Antimicrobial Susceptibility Patterns of KPC-Producing or CTX-M-Producing Enterobacteriaceae
- (2010) Mariana Castanheira et al. Microbial Drug Resistance
- Prospective Observational Study of the Impact of VIM-1 Metallo- -Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
- (2009) G. L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Fosfomycin against blaKPC-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin
- (2009) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Pharmacodynamic Profile of Tigecycline against Phenotypically Diverse Escherichia coli and Klebsiella pneumoniae Isolates
- (2009) A. M. Nicasio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Regional Dissemination of KPC-Producing Klebsiella pneumoniae
- (2009) B. Kitchel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against Klebsiella pneumoniae Producing the KPC Carbapenemase versus That against Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model
- (2009) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo- -Lactamase-Producing Klebsiella pneumoniae Isolates?
- (2009) M. Souli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of a New Metallo- -Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
- (2009) D. Yong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interspecies Spread ofKlebsiella pneumoniaeCarbapenemase Gene in a Single Patient
- (2009) Hanna E. Sidjabat et al. CLINICAL INFECTIOUS DISEASES
- Infection with PanresistantKlebsiella pneumoniae:A Report of 2 Cases and a Brief Review of the Literature
- (2009) Azza Elemam et al. CLINICAL INFECTIOUS DISEASES
- An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes
- (2009) Maria Souli et al. CLINICAL INFECTIOUS DISEASES
- Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials
- (2009) David Gardiner et al. CLINICAL INFECTIOUS DISEASES
- Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study
- (2009) I.P. Korbila et al. CLINICAL MICROBIOLOGY AND INFECTION
- Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
- (2009) A. Michalopoulos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control study
- (2009) Dimitrios K. Matthaiou et al. CRITICAL CARE MEDICINE
- Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
- (2009) Matthew Falagas et al. CURRENT DRUG METABOLISM
- Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem
- (2009) Scott A. Weisenberg et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
- (2009) Nikos Roussos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
- (2009) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult
- (2009) Shmuel Benenson et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Liposomes as delivery systems for antibiotics
- (2009) Zuzanna Drulis-Kawa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin
- (2009) J. Oteo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City
- (2009) S. Bratu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infections with VIM-1 Metallo- -Lactamase-Producing Enterobacter cloacae and Their Correlation with Clinical Outcome
- (2009) M. Falcone et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Decreased Susceptibility to Polymyxin B during Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection
- (2009) J. Lee et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens
- (2009) Garyphallia Poulakou et al. JOURNAL OF INFECTION
- Adjustment of dosing of antimicrobial agents for bodyweight in adults
- (2009) Matthew E Falagas et al. LANCET
- The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
- (2009) Patrice Nordmann et al. LANCET INFECTIOUS DISEASES
- Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
- (2009) Matthew E Falagas et al. LANCET INFECTIOUS DISEASES
- Fatal cross infection by carbapenem-resistantKlebsiellain two liver transplant recipients
- (2009) A.J. Mathers et al. Transplant Infectious Disease
- Subacute Toxicity of Colistin Methanesulfonate in Rats: Comparison of Various Intravenous Dosage Regimens
- (2008) S. J. Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plasmid-Mediated 16S rRNA Methylases among Extended-Spectrum -Lactamase-Producing Enterobacteriaceae Isolates
- (2008) B. Bercot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States
- (2008) S. Navon-Venezia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey
- (2008) A. Carrer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Microbiological Outcomes of Serious Infections with Multidrug-Resistant Gram-Negative Organisms Treated with Tigecycline
- (2008) K. B. Anthony et al. CLINICAL INFECTIOUS DISEASES
- Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal Infections
- (2008) Matthew E. Falagas et al. CLINICAL INFECTIOUS DISEASES
- Clinical Experience of Serious Infections Caused by Enterobacteriaceae Producing VIM-1 Metallo- -Lactamase in a Greek University Hospital
- (2008) M. Souli et al. CLINICAL INFECTIOUS DISEASES
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
- (2008) Nikolaos Markou et al. CLINICAL THERAPEUTICS
- Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin
- (2008) M. E. Falagas et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
- (2008) Gopi Patel et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
- (2008) Theodoros Kelesidis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
- (2008) A. Poudyal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Capsule polysaccharide is a bacterial decoy for antimicrobial peptides
- (2008) E. Llobet et al. MICROBIOLOGY-SGM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now